| Troglitazone | Approved Withdrawn | ADGRG1 | 9289 |
upregulated | troglitazone results in increased expression of ADGRG1 mRNA | 16q21 | |
| Troglitazone | Approved Withdrawn | ADH1B | 125 |
downregulated | troglitazone results in decreased expression of ADH1B mRNA | 4q23 | |
| Troglitazone | Approved Withdrawn | ADH1C | 126 |
downregulated | troglitazone results in decreased expression of ADH1C mRNA | 4q23 | |
| Troglitazone | Approved Withdrawn | ADH4 | 127 |
downregulated | troglitazone results in decreased expression of ADH4 mRNA | 4q23 | |
| Troglitazone | Approved Withdrawn | AGXT2 | 64902 |
downregulated | troglitazone results in decreased expression of AGXT2 mRNA | 5p13.2 | |
| Troglitazone | Approved Withdrawn | AKAP12 | 9590 |
downregulated | troglitazone results in decreased expression of AKAP12 mRNA | 6q25.1 | |
| Troglitazone | Approved Withdrawn | AKR1B10 | 57016 |
upregulated | troglitazone results in increased expression of AKR1B10 mRNA | 7q33 | |
| Troglitazone | Approved Withdrawn | AKR1B15 | 441282 |
upregulated | troglitazone results in increased expression of AKR1B15 mRNA | 7q33 | |
| Troglitazone | Approved Withdrawn | ALDOB | 229 |
downregulated | troglitazone results in decreased expression of ALDOB mRNA | 9q31.1 | |
| Troglitazone | Approved Withdrawn | ALYREF | 10189 |
downregulated | troglitazone results in decreased expression of ALYREF mRNA | 17q25.3 | |
| Troglitazone | Approved Withdrawn | ANG | 283 |
downregulated | troglitazone results in decreased expression of ANG mRNA | 14q11.2 | |
| Troglitazone | Approved Withdrawn | ANGPTL4 | 51129 |
upregulated | troglitazone results in increased expression of ANGPTL4 mRNA | 19p13.2 | |
| Troglitazone | Approved Withdrawn | ANLN | 54443 |
downregulated | troglitazone results in decreased expression of ANLN mRNA | 7p14.2 | |
| Troglitazone | Approved Withdrawn | ANPEP | 290 |
upregulated | troglitazone results in increased expression of ANPEP mRNA | 15q26.1 | |
| Troglitazone | Approved Withdrawn | ANXA10 | 11199 |
downregulated | troglitazone results in decreased expression of ANXA10 mRNA | 4q32.3 | |
| Troglitazone | Approved Withdrawn | ANXA5 | 308 |
upregulated | troglitazone results in increased expression of ANXA5 mRNA | 4q27 | |
| Troglitazone | Approved Withdrawn | APCS | 325 |
downregulated | troglitazone results in decreased expression of APCS mRNA | 1q23.2 | |
| Troglitazone | Approved Withdrawn | APEX2 | 27301 |
downregulated | troglitazone results in decreased expression of APEX2 mRNA | Xp11.21 | |
| Troglitazone | Approved Withdrawn | APOA2 | 336 |
upregulated | troglitazone results in increased expression of APOA2 mRNA | 1q23.3 | |
| Troglitazone | Approved Withdrawn | APOE | 348 |
upregulated | troglitazone results in increased expression of APOE mRNA | 19q13.32 | |
| Troglitazone | Approved Withdrawn | APP | 351 |
upregulated | troglitazone results in increased expression of APP mRNA | 21q21.3 | |
| Troglitazone | Approved Withdrawn | AQP9 | 366 |
downregulated | troglitazone results in decreased expression of AQP9 mRNA | 15q21.3 | |
| Troglitazone | Approved Withdrawn | AR | 367 |
downregulated | troglitazone results in decreased expression of AR mRNA | Xq12 | |
| Troglitazone | Approved Withdrawn | AR | 367 |
downregulated | [troglitazone results in increased degradation of SP1 protein] which results in decreased expression of AR mRNA | Xq12 | |
| Troglitazone | Approved Withdrawn | ARHGEF2 | 9181 |
upregulated | troglitazone results in increased expression of ARHGEF2 mRNA | 1q22 | |